Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul R Wratil

Showing results (21-30 of 29) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 29 results.
Angewandte Chemie (International Ed. in English)|July 8, 2022
Suppression of SARS-CoV-2 Replication with Stabilized and Click-Chemistry Modified siRNAsFranziska R Traube, Marcel Stern, Annika J Tölke, et al.
Infection|August 11, 2021
In-depth profiling of COVID-19 risk factors and preventive measures in healthcare workersPaul R Wratil, Niklas A Schmacke, Andreas Osterman, et al.
Journal of Experimental & Clinical Cancer Research : CR|October 13, 2021
Differences between intrinsic and acquired nucleoside analogue resistance in acute myeloid leukaemia cellsTamara Rothenburger, Dominique Thomas, Yannick Schreiber, et al.
Plos Pathogens|October 6, 2021
Impaired function and delayed regeneration of dendritic cells in COVID-19Elena Winheim, Linus Rinke, Konstantin Lutz, et al.
Infection|May 12, 2025
Effective surveillance of acute COVID-19 using a cost- and labor-efficient approach: a paradigm for the longitudinal monitoring of respiratory infections in larger cohortsPaul R Wratil, Niklas A Schmacke, Burak Karakoc, et al.
Cell Reports|December 21, 2021
Evidence for increased SARS-CoV-2 susceptibility and COVID-19 severity related to pre-existing immunity to seasonal coronavirusesPaul R Wratil, Niklas A Schmacke, Burak Karakoc, et al.
Nature Cancer|December 21, 2022
Potent high-avidity neutralizing antibodies and T cell responses after COVID-19 vaccination in individuals with B cell lymphoma and multiple myelomaAndrea Keppler-Hafkemeyer, Christine Greil, Paul R Wratil, et al.
Nature Medicine|January 28, 2022
Three exposures to the spike protein of SARS-CoV-2 by either infection or vaccination elicit superior neutralizing immunity to all variants of concernPaul R Wratil, Marcel Stern, Alina Priller, et al.
Cell Reports. Medicine|April 5, 2024
Receptor transfer between immune cells by autoantibody-enhanced, CD32-driven trogocytosis is hijacked by HIV-1 to infect resting CD4 T cellsManuel Albanese, Hong-Ru Chen, Madeleine Gapp, et al.
Pageof 3

Showing results (21-30 of 29) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
Angewandte Chemie (International Ed. in English)|July 8, 2022
Suppression of SARS-CoV-2 Replication with Stabilized and Click-Chemistry Modified siRNAsFranziska R Traube, Marcel Stern, Annika J Tölke, et al.
Infection|August 11, 2021
In-depth profiling of COVID-19 risk factors and preventive measures in healthcare workersPaul R Wratil, Niklas A Schmacke, Andreas Osterman, et al.
Journal of Experimental & Clinical Cancer Research : CR|October 13, 2021
Differences between intrinsic and acquired nucleoside analogue resistance in acute myeloid leukaemia cellsTamara Rothenburger, Dominique Thomas, Yannick Schreiber, et al.
Plos Pathogens|October 6, 2021
Impaired function and delayed regeneration of dendritic cells in COVID-19Elena Winheim, Linus Rinke, Konstantin Lutz, et al.
Infection|May 12, 2025
Effective surveillance of acute COVID-19 using a cost- and labor-efficient approach: a paradigm for the longitudinal monitoring of respiratory infections in larger cohortsPaul R Wratil, Niklas A Schmacke, Burak Karakoc, et al.
Cell Reports|December 21, 2021
Evidence for increased SARS-CoV-2 susceptibility and COVID-19 severity related to pre-existing immunity to seasonal coronavirusesPaul R Wratil, Niklas A Schmacke, Burak Karakoc, et al.
Nature Cancer|December 21, 2022
Potent high-avidity neutralizing antibodies and T cell responses after COVID-19 vaccination in individuals with B cell lymphoma and multiple myelomaAndrea Keppler-Hafkemeyer, Christine Greil, Paul R Wratil, et al.
Nature Medicine|January 28, 2022
Three exposures to the spike protein of SARS-CoV-2 by either infection or vaccination elicit superior neutralizing immunity to all variants of concernPaul R Wratil, Marcel Stern, Alina Priller, et al.
Cell Reports. Medicine|April 5, 2024
Receptor transfer between immune cells by autoantibody-enhanced, CD32-driven trogocytosis is hijacked by HIV-1 to infect resting CD4 T cellsManuel Albanese, Hong-Ru Chen, Madeleine Gapp, et al.
Pageof 3